RTTNews | Dec 6, 2021 07:50AM EST

07:50 Monday, December 6, 2021 (RTTNews) - Purple Biotech Initiates Part 2 Of Ongoing Phase 1/2 Trial Evaluating NT219 For Treatment Of Multiple Cancers

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved